Allergy and Immunology · Plymouth, MN
NPI
1811095854
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
15700 37th Ave N, Suites 110 & 230
Plymouth, MN, 55446
Phone (763) 577-0008
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
104,218 services
Medicare patients, 2024
262
Average age 67
Drug cost, 2024
$1.1M
263 prescriptions
Company payments, 2025
$68K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason P Raasch was code J2350 (injection, ocrelizumab, 1 mg), 17,700 times for 27 patients. In total Jason P Raasch billed 104,218 services in 68 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2350 Injection, ocrelizumab, 1 mg | Office | 17,700 | 27 | $46.63 | $825K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 8,820 | 26 | $35.42 | $312K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 8,000 | 15 | $36.73 | $294K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 6,300 | 11 | $8.60 | $54K |
| J0897 Injection, denosumab, 1 mg | Office | 2,100 | 28 | $20.29 | $43K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,097 | 39 | $0.23 | $474 |
| 96366 Intravenous Infusion, Hydration | Office | 327 | 46 | $14.52 | $4,749 |
| 96365 Intravenous Infusion, Hydration | Office | 265 | 72 | $44.43 | $12K |
| 96375 Injection Administration | Office | 181 | 66 | $11.00 | $1,991 |
| 96372 Injection Administration | Office | 173 | 64 | $10.13 | $1,753 |
| J1720 Injection, hydrocortisone sodium succinate, up to 100 mg | Office | 127 | 28 | $14.69 | $1,866 |
| 96413 Chemotherapy Administration | Office | 91 | 60 | $93.71 | $8,527 |
| 96415 Chemotherapy Administration | Office | 74 | 40 | $19.72 | $1,460 |
| 36415 Venipuncture Blood Collection | Office | 39 | 33 | $8.44 | $329 |
| 99214 Office E&M - Established | Office | 32 | 29 | $95.78 | $3,065 |
By year: 2022 $3.2M for 121,326 services; 2023 $3.5M for 128,452 services; 2024 $2.5M for 104,218 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 39 | 33 | $8.44 | $329 |
Medicare prescription drug claims, 2024
In 2024, the drug Jason P Raasch prescribed most often to Medicare patients was Azithromycin, with 28 prescriptions and refills. In total Jason P Raasch wrote 263 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 28 | 48 | Under 11 | $431 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 21 | 21 | Under 11 | $192K |
| Cutaquig Immun Glob G(Igg)-Hipp/Maltose | 20 | 20 | Under 11 | $100K |
| Amoxicillin Generic | 19 | 31 | Under 11 | $243 |
| Cuvitru Immun Glob G(Igg)/Gly/Iga Ov50 | 18 | 18 | Under 11 | $77K |
| Prednisone Generic | 16 | 16 | Under 11 | $55.97 |
| Takhzyro Lanadelumab-Flyo | 14 | 14 | Under 11 | $717K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 12 | 12 | Under 11 | $31K |
Brand drugs: 105 claims; generic drugs: 158 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason P Raasch $68K ($68K in general payments such as food, travel and fees) from 12 companies. The largest payer was Pharming Healthcare, Inc. with $39K.
| Company | Payments | Amount |
|---|---|---|
| Pharming Healthcare, Inc. | 37 | $39K |
| Consortium of Independent Immunology Clinics, LLC | 1 | $16K |
| Ionis Pharmaceuticals, Inc. IONS | 13 | $9,610 |
| CSL Behring CSL.AX | 10 | $3,446 |
| Blueprint Medicines Corporation SNY | 1 | $145 |
| Cycle Pharmaceuticals Inc | 2 | $49.89 |
| GlaxoSmithKline, LLC. GSK | 2 | $29.97 |
| Pfizer Inc. PFE | 1 | $18.61 |
| Phadia US Inc. | 1 | $17.43 |
| GC Biopharma USA, Inc. 006280.KS | 1 | $16.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.